Drug Patent Watch

JANUARY 7, 2025

Generic drugs are pharmaceutical products that contain the same active ingredients as their brand-name counterparts. It’s always a good idea to compare prices at different pharmacies. What Are Generic Drugs? FAQs Q: Are generic drugs always cheaper than brand-name medications? A: In most cases, yes.

Drugs

BioPharma Drive: Drug Pricing

JULY 28, 2025

Unsuitable for standard retail yet not requiring the full infrastructure of specialty pharmacies, these products face unique access barriers that traditional distribution models cant address effectively. Retail Pharmacies : Retail pharmacies present significant challenges in the PA-to-coverage conversion process.

Specialty Pharmacies

Codon

JULY 14, 2025

My goal is not only to tell the story of a pharmaceutical staple but to share what my decades-long work in evidence synthesis in epidemiology has taught me about researching scientific history. I could not find, that it hath, or ever had, any place in pharmacy, or any fuch qualities, as I fufpected afcribed to it by the botanifts.

Treatment

Drug Channels

APRIL 15, 2025

In todays fast-moving pharmaceutical marketplace, insight is everything. Whether you're building trust with customers, launching new products, or guiding internal teams, understanding the economic forces that shape drug distribution, reimbursement, and pricing is essential. pharmaceutical distribution.

Specialty Pharmacies

Drug Channels

APRIL 8, 2022

Michael discusses patient support challenges that are unique to specialty-lite pharmaceuticals. He goes on to describe four new categories of patient solutions and pharmacy models specific to this growing market segment.

Specialty Pharmacies

Drug Channels

MAY 9, 2022

Informa Connect’s Hub and Specialty Pharmacy Models East. June 28-30, 2022 | Sheraton Parsippany | Parsippany, NJ www.informaconnect.com/hub-specialty-pharmacy. Attorney’s Office, District of New Jersey Lauren Powell, MPA, PhD, Vice President, US Health Equity & Community Wellness, Takeda Pharmaceuticals PLUS! Attorney, U.S.

Specialty Pharmacies

BioPharma Drive: Drug Pricing

JULY 22, 2025

This database now covers the 50 best-selling pharmaceutical products and has been updated to reflect current patent expiry expectations. This database now covers the 50 best-selling pharmaceutical products and has been updated to reflect current patent expiry expectations. Track when they’ll expire.

FDA

Drug Channels

OCTOBER 21, 2024

Informa Connect’s Trade and Channel Strategies December 10-12, 2024 at the W Hotel in Philadelphia, PA Drug Channels readers save 10% with code 24DC10 * Pharmacy and distribution models are growing increasingly complex. Is my organization haemorrhaging money to stay afloat with the shift to alternative distribution and pharmacy models?

Specialty Pharmacies

Drug Channels

OCTOBER 3, 2023

This week, I’m rerunning some popular posts while I put the finishing touches on our new 2023-24 Economic Report on Pharmaceutical Wholesalers and Specialty Distributors. This month, nine biosimilar versions of adalimumab launched in the U.S. No biosimilar has the trifecta of being high-concentration, citrate-free, and fully interchangeable.

Biosimilars

Drug Channels

SEPTEMBER 2, 2020

This week, I’m rerunning some popular posts while I work on the forthcoming 2020-21 Economic Report on Pharmaceutical Wholesalers and Specialty Distributors. I'm rerunning this post to provide context for manufacturers' recent actions regarding 340B contract pharmacies. per 3 mL pen or $0.10 per 10 mL vial.

Pharmacy

Drug Channels

SEPTEMBER 13, 2023

For 2023, specialty pharmacies—via white, brown, and clear bagging—retained a meaningful share of the distribution channels for provider-administered oncology drugs. Despite the concerted efforts of insurers such as UnitedHealthcare and Elevance Health, however, buy-and-bill remains the most common channel for these products.

Specialty Pharmacies

Drug Channels

DECEMBER 13, 2023

For 2023, specialty pharmacies—via white, brown, and clear bagging—retained a meaningful share of the distribution channels for provider-administered oncology drugs. Despite the concerted efforts of insurers such as UnitedHealthcare and Elevance Health, however, buy-and-bill remains the most common channel for these products.

Specialty Pharmacies

The Pharma Data

JULY 29, 2021

Food and Drug Administration approved the first interchangeable biosimilar insulin product, indicated to improve glycemic control in adults and pediatric patients with Type 1 diabetes mellitus and in adults with Type 2 diabetes mellitus. Semglee (insulin glargine-yfgn) is the first interchangeable biosimilar product approved in the U.S.

Biosimilars

Drug Channels

OCTOBER 23, 2023

With regulation and policy changes, specifically surrounding the DCSCA, IRA and serialization, the loss of exclusivity wave, adoption of low-WAC products affecting GTN and the rise of alternative distribution models, there has never been a more important time for industry to unite. How is health policy affecting the distribution channel?

Pharmacy

Alta Sciences

DECEMBER 14, 2023

A Closer Look At Our On-Site Compounding Pharmacies shajjar Thu, 12/14/2023 - 21:30 HTML Altasciences' dedicated pharmacists bring a wealth of expertise in controlled substances and complex compounding, ensuring maximum precision and safety standards. Electronic security access to the pharmacy and video monitoring. -

Compounding Pharmacies

Policy Prescription

OCTOBER 3, 2023

Salant’s paper supports personal drug importation and legalizing the importation of prescription drugs for commercial use so that wholesale pharmacies, including companies like Amazon and Costco, could tap into the parallel importation markets of other countries. Third, even foreign drug prices are much higher than the cost of production.

Pharmacy

The Pharma Data

SEPTEMBER 21, 2020

Acella Pharmaceuticals is recalling two types of its thyroid medication as the drugs may be too weak to properly treat those who take them. . Photo by Adam from UK. This follows a similar recall of thyroid medications that was issued by the FDA in recent weeks.

Pharmaceuticals

Drug Channels

APRIL 19, 2021

Informa Connect’s Compliance Congress for Specialty Products. Up your compliance game at this important event serving the unique sector of Specialty Products, the 7th annual Virtual Compliance Congress for Specialty Products. June 22-24, 2021 | Virtual Event www.informaconnect.com/specialty-compliance/.

Compliance

Drug Channels

SEPTEMBER 11, 2024

For 2024, payers report that specialty pharmacies—via white and clear bagging—have displaced buy-and-bill for a meaningful share of commercial covered lives utilizing provider-administered oncology drugs. Payers’ adoption of white bagging—and provider’s push back—reflect the ongoing battle for oncology margin in U.S. drug channels.

Specialty Pharmacies

Drug Channels

DECEMBER 10, 2024

Last week, the Federal Trade Commission (FTC) released its interim report on pharmacy benefit managers (PBMs). The reports unsubtle subtitle revealed how the agency views PBMs: The Powerful Middlemen Inflating Drug Costs and Squeezing Main Street Pharmacies. Pharmacies and Pharmacy Benefit Managers.

Pharmacy

Drug Channels

SEPTEMBER 21, 2020

This important event convenes key stakeholders including manufacturers, specialty pharmacies, hubs, payers, PBMs, physicians and more to explore strategies for developing and integrating hub programs and other patient-centric services to ensure product access and optimal reimbursement. Arquette, R.Ph., REGISTER TODAY.

Specialty Pharmacies

The Pharma Data

OCTOBER 19, 2020

20, 2020 /PRNewswire/ — Abarca , a pharmacy benefit manager (PBM) that is disrupting the industry with a new approach to technology and business practices released a new case study detailing a value-based agreement with Biogen Inc. It started by redefining pharmacy benefits, but this is just the beginning.

Production

DrugBank

SEPTEMBER 26, 2024

This reduction in cost does not equate to a compromise in quality or efficacy, as biosimilars undergo rigorous analytical and functional characterization to demonstrate biosimilarity to the reference product. biosimilars are often priced slightly lower than their reference products, limiting their potential for cost savings.

Biosimilars

Drug Channels

JULY 16, 2024

Last week, the Federal Trade Commission (FTC) released its interim report on pharmacy benefit managers (PBMs). The report’s unsubtle subtitle revealed how the agency views PBMs: The Powerful Middlemen Inflating Drug Costs and Squeezing Main Street Pharmacies. Pharmacies and Pharmacy Benefit Managers.

Pharmacy

Drug Channels

JULY 20, 2021

The 340B Drug Pricing Program continues to expand far more quickly than the overall pharmaceutical market—and some channels are benefiting more than others. As you will see below, mail and specialty pharmacies’ purchases of products that are eligible for 340B discounts have grown by an incredible 56% per year since 2017.

Specialty Pharmacies

Policy Prescription

APRIL 1, 2022

from licensed pharmacies to American patients. This epic counterfeit drug debacle had nothing to do with the personal importation of less expensive prescription drugs or foreign online pharmacies. pharmacies and wholesalers allegedly flouting the rules. Safe Chain Pharmacy Solutions. Fake DSCSA Pedigrees.

Pharmacy

Agency IQ

JANUARY 4, 2024

Now, the FDA has released guidance laying out the tests and regulatory submissions needed for the reformulation of products containing these ingredients. To help control impurities, the FDA requires all starting materials used in drug manufacturing and final pharmaceutical products to be evaluated for “identity, strength, quality and purity.”

FDA

Fierce BioTech

JANUARY 19, 2024

The Cardinal Health™ Sonexus™ Access and Patient Support team will explore innovative ways to create efficiencies and improve the patient experience with AI-powered patient access backed by best-in-class pharmacy and operations.

Pharmacy

FDA Law Blog: Biosimilars

FEBRUARY 5, 2024

HP&M has been helping clients navigate the challenges of state licensing regulations for drugs, biologics, medical devices, OTCs, 503B outsourcing facilities, 503A pharmacies, foods, dietary supplements, cannabis, and wholesalers/distributors for many years. Keup has joined the firm to assist attorneys Karla L.

Licensing

The Pharma Data

DECEMBER 19, 2020

McKesson has a long history of managing the pharmaceutical and medical supply chain in the U.S., For the ancillary supply kit production and distribution, McKesson has partnered with the Strategic National Stockpile, which is part of the Office of the Assistant Secretary for Preparedness and Response within HHS.

Government

The Pharma Data

NOVEMBER 1, 2020

It is a very exciting step for our Pharmaceutical Wholesale Division and a unique chance for us to further develop innovative services to manufacturers and pharmacists in Germany.”. Together, we look forward to delivering a successful model of operations to benefit the German healthcare ecosystem of patients, pharmacies and manufacturers.”.

Pharmacy

FDA Law Blog: Biosimilars

MARCH 4, 2024

Livornese — On February 6, 2024, FDA issued a draft guidance titled Notifying FDA of a Discontinuance or Interruption in Manufacturing of Finished Products or Active Pharmaceutical Ingredients Under Section 506C of the FD&C Act.

FDA

Drug Target Review

AUGUST 16, 2024

I joined the pharmaceutical industry to leverage my passion and hands-on clinical experience to care for people all over the world by bringing a unique perspective to drug and device research and development. Here, I oversee the medical strategy for both existing products and those in our development pipeline, including outcomes research.

Medical Schools

Drug Channels

MARCH 29, 2021

We’ve got all of the key legal and consultant perspectives on topics like 340B (including contract pharmacy arrangements), State Price Transparency, CMS current and final rules, Most Favored Nations, and more! Fresh Perspectives.

Government

Drug Channels

MARCH 29, 2021

We’ve got all of the key legal and consultant perspectives on topics like 340B (including contract pharmacy arrangements), State Price Transparency, CMS current and final rules, Most Favored Nations, and more! Fresh Perspectives.

Government

Drug Channels

JANUARY 4, 2021

Dave MacLeod, Head of Patient Services and Specialty Pharmacy Operations , Amylyx Pharmaceuticals Deepti Jaggi, Global Head of Patient Insights and Solutions , Astellas US Marina Allen, Executive Director, Patient Access and Reimbursement , Coherus BioSciences And more! Jourdan Russo, Director, Patient Services , Kyowa Kirin, Inc.

Specialty Pharmacies

The Pharma Data

JANUARY 13, 2021

. Psychedelic Pharmaceutical Scientist and Clinical Pharmacologist Robert Barrow Appointed as Chief Development Officer. NEW YORK , Jan.

Clinical Trials